J. Boniface

发表

Discovery and Verification of Extracellular miRNA Biomarkers for Non-invasive Prediction of Pre-eclampsia in Asymptomatic Women

J. Burchard, L. Laurent, G. Saade, 2020, Cell reports. Medicine.

LIGAND RECOGNITION BY T CELL RECEPTORS

Mark M. Davis, Y. Chien, Z. Reich, 1998 .

Ligand recognition by alpha beta T cell receptors.

Z Reich, Y. Chien, M. Davis, 1998, Annual review of immunology.

Clinical Validation of a Proteomic Biomarker Threshold for Increased Risk of Spontaneous Preterm Birth and Associated Clinical Outcomes: A Replication Study

J. Burchard, G. Saade, P. Kearney, 2021, medRxiv.

The building blocks of successful translation of proteomics to the clinic

L. Hood, N. Price, P. Kearney, 2018, Current opinion in biotechnology.

pH affects both the mechanism and the specificity of peptide binding to a class II major histocompatibility complex molecule.

L. Stryer, N. Allbritton, M. Davis, 1993, Biochemistry.

T-cell recognition of antigen. A process controlled by transient intermolecular interactions.

M. Davis, J. Boniface, 1995, Annals of the New York Academy of Sciences.

T‐Cell Recognition of Antigen

Mark M. Davis, J. Boniface, Mark M. Davis, 1995 .

J. Burchard, G. Saade, J. Boniface, 2020, Obstetrics and gynecology.

Evidence for a conformational change in a class II major histocompatibility complex molecule occurring in the same pH range where antigen binding is enhanced

N. Allbritton, M. Davis, D. Wettstein, 1996, The Journal of experimental medicine.

Stability of empty and peptide-loaded class II major histocompatibility complex molecules at neutral and endosomal pH: comparison to class I proteins.

J. Altman, G. Ogg, M. Davis, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Expression of a class II major histocompatibility complex (MHC) heterodimer in a lipid-linked form with enhanced peptide/soluble MHC complex formation at low pH

M. Davis, D. Wettstein, P. Reay, 1991, The Journal of experimental medicine.

Effects of Onion Juice and Moringa oleifera Leaf Juice on the Shelf Life of Sugarcane Juice

L. Rweyemamu, J. Boniface, H. Msita, 2020 .

Clinical and economic utility of a preterm birth predictor derived from an analysis of a large and diverse pregnancy cohort

J. Burchard, L. Laurent, G. Saade, 2021, medRxiv.

Two-dimensional nuclear magnetic resonance analysis of a labeled peptide bound to a class II major histocompatibility complex molecule.

K. Sakaguchi, J. Altman, M. Davis, 1993, Journal of molecular biology.

Better Estimation of Spontaneous Preterm Birth Prediction Performance through Improved Gestational Age Dating

J. Burchard, G. Saade, P. Kearney, 2022, Journal of clinical medicine.

Expression screen by enzyme-linked immunofiltration assay designed for high-throughput purification of affinity-tagged proteins.

J. Savage, T. Zarembinski, J. Boniface, 2003, Analytical biochemistry.

The Kinetics of Binding of Peptide/MHC Complexes to T-Cell Receptors: Application of Surface Plasmon Resonance to a Low-Affinity Measurement

Mark M. Davis, J. Boniface, 1994 .

Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands [corrected].

J. Altman, M. Davis, Z. Reich, 1998, Immunity.

Development and validation of a proteomic biomarker risk predictor for preterm preeclampsia in asymptomatic women

Md. Bahadur Badsha, J. Burchard, A. Polpitiya, 2022, medRxiv.

RAS–RAF–MEK-dependent oxidative cell death involving voltage-dependent anion channels

B. Stockwell, S. Sahasrabudhe, J. Peltier, 2007, Nature.

A synthetic peptide corresponding to hFSH-β-(81–95) has thioredoxin-like activity

J. Boniface, L. Reichert, P. Grasso, 1991, Molecular and Cellular Endocrinology.

Evidence for a novel thioredoxin-like catalytic property of gonadotropic hormones.

J. Boniface, L. Reichert, Leo E. Reichert, 1990, Science.

Formation of a highly peptide-receptive state of class II MHC.

M. Vrljic, M. Davis, P. Kasson, 1998, Immunity.

Conformational isomers of a class II MHC-peptide complex in solution.

M. Davis, H. Mcconnell, J. Boniface, 1999, Journal of molecular biology.

6LB The Nampt inhibitor MPC-9528 and the PARP inhibitor olaparib synergize in killing a BRCA-deficient cancer cell line

T. Fleischer, J. Boniface, R. Carlson, 2010 .

Commentary on a combined approach to the problem of developing biomarkers for the prediction of spontaneous preterm labor that leads to preterm birth.

R. Menon, R. Khan, C. Vinter, 2020, Placenta.

The Immunological Evolution of Catalysis

Peter G. Schultz, Raymond C. Stevens, Nathanael S. Gray, 1996, Science.

Performance of a proteomic preterm delivery predictor in a large independent prospective cohort.

J. Burchard, L. Laurent, G. Saade, 2020, American journal of obstetrics & gynecology MFM.

Development and validation of a spontaneous preterm delivery predictor in asymptomatic women.

Matthew K Hoffman, Ashoka D Polpitiya, Emanuele Mazzola, 2016, American journal of obstetrics and gynecology.

Ligand-specific oligomerization of T-cell receptor molecules

Mark M. Davis, E. Wachtel, Z. Reich, 1997, Nature.

A kinetic basis for T cell receptor repertoire selection during an immune response.

M. Davis, J. Boniface, M M Davis, 1999, Immunity.

A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists.

Y. Chien, M. Davis, L. Berg, 1996, Immunity.

Cost-Effectiveness of a Proteomic Test for Preterm Birth Prediction

J. Zupancic, J. Burchard, E. Stanek, 2021, ClinicoEconomics and outcomes research : CEOR.

Thermodynamics of T cell receptor binding to peptide-MHC: evidence for a general mechanism of molecular scanning.

Z Reich, M. Davis, Z. Reich, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness.

M. Davis, P. Reay, J. Boniface, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Low affinity interaction of peptide-MHC complexes with T cell receptors.

M. Davis, B. Fazekas de St. Groth, P. Reay, 1991, Science.

Engineering and expression of a secreted murine TCR with reduced N-linked glycosylation.

D. M. Penny, L. Weiner, P. Bjorkman, 1994, Journal of immunology.

T cell receptor biochemistry, repertoire selection and general features of TCR and Ig structure.

Y. Chien, J. Altman, M. Davis, 1997, Ciba Foundation symposium.

An integrated strategy for the discovery of drug targets by the analysis of protein–protein interactions

R. Becklin, J. Savage, C. L. Chepanoske, 2004 .

Chemical proteomics identifies Nampt as the target of CB30865, an orphan cytotoxic compound.

Brett R. Murphy, T. Fleischer, J. Flick, 2010, Chemistry & biology.

CEOR_A_325094 809..820

J. Zupancic, J. Burchard, E. Stanek, 2021 .

PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

J. Boniface, Mark M. Davis, 2001 .

Performance of a validated spontaneous preterm delivery predictor in South Asian and Sub-Saharan African women: a nested case control study

Md. Bahadur Badsha, J. Burchard, N. Iqbal, 2021, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

Effects of Selective Exclusion of Patients on Preterm Birth Test Performance.

J. Burchard, G. Saade, J. Boniface, 2019, Obstetrics and gynecology.

Analytical validation of protein biomarkers for risk of spontaneous preterm birth

J. Peltier, P. Kearney, S. Hunsucker, 2017 .

337: Use of a second trimester serum-based proteomic risk classifier for prediction of spontaneous and medically-indicated preterm birth

G. Saade, P. Kearney, A. Polpitiya, 2017 .

Effects of Selective Exclusion of Patients on Preterm Birth Test Performance

J. Burchard, G. Saade, J. Boniface, 2019, Obstetrics and gynecology.

J. Burchard, G. Saade, J. Boniface, 2020, Obstetrics and gynecology.

Kinetic isomers of a class II MHC-peptide complex.

M. Davis, H. Mcconnell, J. Boniface, 1998, Biochemistry.

Abstract B137: Pharmacokinetics, antitumor activity, and therapeutic index of Nampt inhibitor MPC-8640 in mice.

V. Baichwal, J. Boniface, R. Carlson, 2011 .

Abstract 3526: Coadministration of nicotinic acid with the Nampt inhibitor MPC-9528 enhances antitumor activity in Naprt deficient cancer cells in culture and in xenografts

V. Baichwal, T. Fleischer, J. Boniface, 2011 .

Analogues of 4-[(7-Bromo-2-methyl-4-oxo-3H-quinazolin-6-yl)methylprop-2-ynylamino]-N-(3-pyridylmethyl)benzamide (CB-30865) as potent inhibitors of nicotinamide phosphoribosyltransferase (Nampt).

Brett R. Murphy, T. Fleischer, J. Boniface, 2010, Journal of medicinal chemistry.

Abstract 3673: Identifying the target of an orphan compound: CB30865 is a Nampt inhibitor

Brett R. Murphy, T. Fleischer, J. Flick, 2010 .